TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology December 6, 1996